Big Buttons

• CALL TO ACTION: Tell FDA to deny drugmakers’ request

  Drugmakers are urging FDA to prohibit compounded GLP-1s. FDA needs to hear from you and your patients NOW! read more →

• APC to FDA: Just say no to Lilly

  This week APC's lawyers sent a formal comment to the FDA about Eli Lilly’s request that tirzepatide be added to the Demonstrably Difficult to Compound list. read more →

• California BOP sends proposed compounding regs to comment period

  The California State Board of Pharmacy decided to move the modified proposed sterile compounding regulations forward to a 30-day comment period. read more →

• Checking in on the post-Chevron fallout

  What’s happened in the world of federal regulation since the end of Chevron? read more →

• Hi, Noom!

  Welcome to our newest Bronze-level Corporate Patron, Noom! read more →

• PFMs can get 2.5% credit card processing

  A new benefit for APC’s Pharmacy/Facility Members: They may be able to cut their credit card processing fees to just 2.5% – 2.8%. read more →

• Phoenix compounders, rise!

  The latest of APC’s new regional meetings — CompoundED UpDATE — is coming to the Phoenix area December 5. read more →

• APC election results: directors and bylaws

  See the results of APC's elections, including four new directors and several changes to our bylaws. read more →

More News

A new benefit for APC Pharmacy/Facility Members is discounted pricing on Love Lifesciences’ UniPen injector pen — it’s similar to ‘dial-a-dose’ injectors used by insulin pens and brand-name GLP-1 drugs, and it can be easier for some patients to use than a traditional needle and vial. 

This is the first product of its kind we’ve seen, and considering the number of injectable meds on the market, it could — dare we say it? — be a game-changer for patients who use injectable drugs. Love also says it can help increase adherence and make it easier to choose the correct dose.

(Not a PFM? Learn more about all the benefits at a4pc.org/pfm.)